Early Cancer Detection
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT04530006
Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Phase: N/A
Role: Collaborator
Start: Dec 2, 2020
Completion: Aug 31, 2025
Loading map...